Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.100
+0.1600.32%
Volume:27.39M
Turnover:1.38B
Market Cap:208.22B
PE:36.88
High:51.150
Open:49.960
Low:49.740
Close:49.940
52wk High:54.450
52wk Low:28.480
Shares:4.16B
HK Float Shares:4.16B
Volume Ratio:0.94
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.358
ROE:11.38%
ROA:7.60%
PB:3.70
PE(LYR):36.88
PS:7.53

Loading ...

TOT Biopharm Schedules Board Meeting to Review Interim Results

Reuters
·
Jul 10

Wuxi XDC Schedules Board Meeting to Review Interim Results

Reuters
·
Jul 10

Wuxi Biologics (cayman) Stock Rises 2.4% in Hong Kong

Dow Jones
·
Jul 10

Movement Alert|WuXi Biologics Rises 3.45% in Regular Trading, MFG8 Drug Substance Facility FDA Approval Continues to Boost Sentiment

Market Focus
·
Jul 10

Wuxi Biologics (cayman) Stock Rallies 3.9% in Hong Kong

Dow Jones
·
Jul 09

Wuxi Biologics' MFG8 Drug Substance Facility Secures FDA Pli Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy

THOMSON REUTERS
·
Jul 09

WUXI BIO Shares Surge Over 6% as MFG8 Facility Passes Key FDA Pre-Approval Inspection

Deep News
·
Jul 09

Wuxi Biologics’ MFG8 Drug Substance Plant Passes FDA Pre-license Inspection

Reuters
·
Jul 09

Movement Alert|WuXi Biologics Rises 3.03% in Regular Trading, Sector Rebound Combined with Sustained High-Frequency Buybacks Boost Confidence

Market Focus
·
Jul 09

Movement Alert|WuXi Biologics Declines 3.05% in Regular Trading, Life Sciences Sector Weakens for Second Consecutive Day

Market Focus
·
Jul 08

Wuxi Biologics Retains MSCI ESG AAA Rating for Fourth Straight Year Under Model 5.0

Reuters
·
Jul 08

WuXi Biologics lifts share capital by 0.005%, repurchases 2.72 million shares for HK$99.82 million; cumulative buy-backs reach HK$1.27 billion

Bulletin Express
·
Jul 07

WUXI BIO Executes Major Share Buyback on July 7

Stock News
·
Jul 07

Wuxi Biologics Files HKEX Next-day Disclosure Showing 206,000 New Shares Issued Via Option Exercises

Reuters
·
Jul 07

Wuxi Biologics (cayman) Stock Falls 2.7% in Hong Kong

Dow Jones
·
Jul 07

Movement Alert|WuXi Biologics Falls 3.02% in Regular Trading, Trading at HKD 36.68

Market Focus
·
Jul 07

WUXI BIO Issues 2.45 Million New Shares in June; Authorized Capital Steady, Public Float Intact

Bulletin Express
·
Jul 06

Movement Alert|WuXi Biologics Rises 3.09% in Regular Trading, Sustained High-Frequency Buybacks and Sector Strength Drive Gains

Market Focus
·
Jul 06

Is WuXi Biologics (Cayman) (SEHK:2269) Undervalued On ANVISA GMP Approval?

Simply Wall St.
·
Jul 03

Wuxi XDC Files HKEX Next-day Disclosure Return, Issues 263,203 New Shares to Lift Share Capital

Reuters
·
Jul 03